NYSEARCA:MSGR Morningstar US Small Growth (MSGR) Price, Holdings, & News → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free MSGR Stock Alerts $13.91 0.00 (0.00%) (As of 05/12/2023) Add Compare Share Share Today's Range$13.91▼$13.9150-Day Range$13.91▼$13.9152-Week Range$11.55▼$17.40VolumeN/AAverage Volume3,376 shsMarket Capitalization$3.06 millionAssets Under Management$3.10 millionDividend Yield2.46%Net Expense Ratio0.65% Stock AnalysisStock AnalysisRatingsStock AnalysisRatings Get Morningstar US Small Growth alerts: Email Address About Morningstar US Small GrowthThe Direxion mRNA ETF (MSGR) is an exchange-traded fund that is based on the BITA Messenger RNA Technology index, a market-cap-weighted index of companies from the US, Canada, and Europe that contribute to the development and application of messenger RNA (mRNA) technology. MSGR was launched on Dec 9, 2021 and is managed by Direxion.Read More MSGR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MSGR ETF News HeadlinesFebruary 22, 2023 | money.usnews.comDirexion Hydrogen ETFJanuary 22, 2023 | finance.yahoo.comDirexion mRNA ETF (MSGR)April 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.October 21, 2022 | finance.yahoo.comDIREXION SH ETF TR (^TSLL)See More Headlines Receive MSGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Morningstar US Small Growth and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerDirexion Fund NameDirexion mRNA ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:MSGR Inception Date12/9/2021 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkBITA Messenger RNA Technology Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings4 Fund Statistics Assets Under Management$3.10 million Average Daily Volume$0.00 Discount/Premium0.13% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerSusquehanna Miscellaneous Outstanding Shares220,000Beta0.88 Creation Unit25,000 Creation Fee$250.00 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Morningstar US Small Growth ExpensesTypeMSGRTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.60%0.57%0.54%0.50%0.51%Other Expenses0.05%0.72%0.54%0.64%0.58%Total Expense0.65%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.76%-0.55%-0.68%-0.57%Net Expense0.65%0.59%0.60%0.58%0.58% Morningstar US Small Growth (MSGR) HoldingsTop 10 MSGR HoldingsVertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 8.06%Scilex(NASDAQ:SCLX)Holding Weight: 7.99%Arcturus Therapeutics(NASDAQ:ARCT)Holding Weight: 7.01%BeiGene(NASDAQ:BGNE)Holding Weight: 6.93%Alnylam Pharmaceuticals(NASDAQ:ALNY)Holding Weight: 6.62%Moderna(NASDAQ:MRNA)Holding Weight: 6.44%BioNTech(NASDAQ:BNTX)Holding Weight: 6.17%Sarepta Therapeutics(NASDAQ:SRPT)Holding Weight: 5.97%PTC Therapeutics(NASDAQ:PTCT)Holding Weight: 5.78%Maravai LifeSciences(NASDAQ:MRVI)Holding Weight: 4.94%Full Holdings Details Similar ETFsRoundhill MEME ETFNYSEARCA:MEMEBlackRock Future Climate and Sustainable Economy ETFNYSEARCA:BECODirexion Daily US Infrastructure Bull 2X SharesNYSEARCA:DOZRHypatia Women CEO ETFNYSEARCA:WCEODirexion Breakfast Commodities Strategy ETFNYSEARCA:BRKY MSGR ETF - Frequently Asked Questions How have MSGR shares performed in 2024? Morningstar US Small Growth's stock was trading at $13.91 on January 1st, 2024. Since then, MSGR shares have increased by 0.0% and is now trading at $13.9102. View the best growth stocks for 2024 here. What does MSGR invest in? Morningstar US Small Growth is a equity fund issued by Direxion. MSGR focuses on theme investments and follows the BITA Messenger RNA Technology Index. The fund's investments total to approximately $3.10 million assets under management. What stocks does Morningstar US Small Growth hold? MSGR invests in 4 holdings. Some of the stocks in their portfolio include Vertex Pharmaceuticals (VRTX), Scilex (SCLX), Arcturus Therapeutics (ARCT), BeiGene (BGNE), Alnylam Pharmaceuticals (ALNY), Moderna (MRNA), BioNTech (BNTX), Sarepta Therapeutics (SRPT), PTC Therapeutics (PTCT) and Maravai LifeSciences (MRVI). What is the management fee for Morningstar US Small Growth? Morningstar US Small Growth's management fee is 0.60% and has other expenses of 0.05%. The net expense ratio for MSGR is 0.65%. How do I buy shares of Morningstar US Small Growth? Shares of MSGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:MSGR) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Morningstar US Small Growth Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.